SCHEMBL4960913

SCHEMBL4960913

COC(=O)c1n[nH]c(-c2ccc(SC)cc2)c1CC1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.41
CDK1 P06493 4/20 0.41
CCNB2 O95067 3/20 0.41
CCNB1 P14635 3/20 0.41
GSK3A P49840 3/20 0.41
CCNB3 Q8WWL7 3/20 0.41
METAP2 P50579 1/20 0.38
RAB9A P51151 1/20 0.36
ADORA2A P29274 1/20 0.35
ALDH1A1 P00352 5/20 0.35
HPGD P15428 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 1/20 0.35
PLK4 O00444 1/20 0.34
PDPK1 O15530 1/20 0.34
DAPK3 O43293 1/20 0.34
PRKD3 O94806 1/20 0.34
MAP4K4 O95819 1/20 0.34
CHEK2 O96017 1/20 0.34
RET P07949 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4957792 0.85 CCNB2 (0.41) GSK3BCDK1CCNB2CCNB1GSK3A
SCHEMBL5150592 0.82 ALDH1A1 (0.36) METAP2RAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL6444360 0.82 ALDH1A1 (0.36) METAP2RAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL4957820 0.79 CDK1 (0.36) GSK3BCDK1CCNB2CCNB1GSK3A
SCHEMBL4958426 0.78 RARB (0.41) GSK3BCDK1CCNB2CCNB1GSK3A
SCHEMBL4958956 0.76 CCNB2 (0.35) GSK3BCDK1CCNB2CCNB1GSK3A
SCHEMBL6441497 0.72 ALDH1A1 (0.53) RAB9AALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL6441172 0.71 ALDH1A1 (0.41) RAB9AALDH1A1SMN1; SMN2LMNAKDM4E
SCHEMBL6441245 0.71 MAPT (0.45) GSK3BRAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL6440359 0.71 ALDH1A1 (0.41) GSK3BGSK3ARAB9AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1542972-A4 CYCLOOXYGENASE- 2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE NITROMED INC (US) 2008-01-23 EP disclosed
EP-1542972-A2 CYCLOOXYGENASE- 2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE Nitromed, Inc. (US) 2005-06-22 EP disclosed
WO-2004010945-A2 CYCLOOXYGENASE- 2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE NITROMED, INC. (US) 2004-02-05 WO disclosed